Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tablet program aims to curb teen suicide in rural ERs

NCT ID NCT07325474

Knowledge-focused Sponsor: Dartmouth-Hitchcock Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 05, 2026 · Updated 5 times

Summary

This study tests a tablet-based program called Plan & Protect for teens aged 12-17 who visit rural emergency departments with suicidal thoughts or self-harm. The program helps teens and their caregivers create a personalized safety plan and reduce access to firearms and medications at home. Researchers will compare outcomes for families who use the program to those who receive usual care, measuring changes in home safety and suicide risk over three months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Plan & Protect safety planning intervention (behavioral program)
What this could lead to
If successful, this could provide a practical, culturally sensitive tool to reduce suicide risk and improve home safety for at-risk teens in rural areas.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. The program's effectiveness may vary across different rural settings and populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 550 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Apr 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for children: * 12-17 years of age (and their parent/caregiver(s)) * Ability to speak and complete surveys in English * History of emergency department visit for suicidality, self-harm or mental health crisis * Medically stable Exclusion criteria for children: * Cognitive or developmental delays that preclude program participation based on clinical team assessment * Diagnosis of psychosis * Primary diagnosis of an eating disorder * Parent/guardian not able to provide consent in English * Clinical team concern for patient or staff safety based upon active behavioral concerns * Parent/guardian not available to provide consent (e.g youth is in child protective custody/ward of the state) Inclusion criteria for parents/caregivers: * Parent or caregiver of an eligible child * 18 years old or older * Ability to speak and complete surveys in English Exclusion criteria for parents/caregivers: -Inability to understand key aspects of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicide attempt are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Suicide attempt Suicide ideation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alice Peck Day Memorial Hospital

    Lebanon, New Hampshire, 03766, United States

  • Cheshire Medical Center

    Keene, New Hampshire, 03431, United States

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, 03756, United States

  • New London Hospital

    New London, New Hampshire, 03257, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.